CA - Crescita Therapeutics GAAP EPS of C$0.00 revenue of C$6.51M August, 10 2022 08:27 AM CA Inc. Crescita Therapeutics press release ( OTCPK:CRRTF ): Q2 GAAP EPS of C$0.00. Revenue of C$6.51M (+121.4% Y/Y). For further details see: Crescita Therapeutics GAAP EPS of C$0.00, revenue of C$6.51M